NewslettersHepatic Cell NewsUS FDA Approves First Drug for Fatty Liver Disease NASHBy lbeveridge - March 15, 2024017The US FDA has approved Madrigal Pharmaceuticals’ drug for a fatty liver disease known as non-alcoholic steatohepatitis (NASH), the first treatment to get the nod for the condition and opening up a multi-billion dollar opportunity.[Reuters]Press Release